Literature DB >> 20584544

Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine.

Anne Balloch, Paul V Licciardi, Fiona M Russell, Edward K Mulholland, Mimi L K Tang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20584544      PMCID： PMC2917627          DOI： 10.1016/j.jaci.2010.05.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells.

Authors:  M J Peset Llopis; G Harms; M J Hardonk; W Timens
Journal:  J Allergy Clin Immunol       Date:  1996-04       Impact factor: 10.793

2.  Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance.

Authors:  A Balloch; P V Licciardi; A Leach; A Nurkka; M L K Tang
Journal:  Vaccine       Date:  2009-11-21       Impact factor: 3.641

3.  Pneumococcal vaccine: time for another controlled trial.

Authors:  F Shann
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

4.  A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers.

Authors:  M D Blum; R Dagan; P M Mendelman; V Pinsk; M Giordani; S Li; N Bohidar; T B McNeely
Journal:  Vaccine       Date:  2000-05-08       Impact factor: 3.641

5.  Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

Authors:  F M Russell; J R Carapetis; A Balloch; P V Licciardi; A W J Jenney; L Tikoduadua; L Waqatakirewa; J Pryor; J Nelson; G B Byrnes; Y B Cheung; M L K Tang; E K Mulholland
Journal:  Vaccine       Date:  2010-03-04       Impact factor: 3.641

6.  Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine.

Authors:  S Zielen; I Bühring; N Strnad; J Reichenbach; D Hofmann
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines.

Authors:  M A Breukels; A Zandvoort; G T Rijkers; M E Lodewijk; P A Klok; G Harms; W Timens
Journal:  Scand J Immunol       Date:  2005-04       Impact factor: 3.487

8.  Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations.

Authors:  R U Sorensen; L E Leiva; F C Javier; D M Sacerdote; N Bradford; B Butler; P A Giangrosso; C Moore
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

9.  Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

Authors:  W S Pomat; D Lehmann; R C Sanders; D J Lewis; J Wilson; S Rogers; T Dyke; M P Alpers
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441
  9 in total
  12 in total

1.  Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.

Authors:  Paul V Licciardi; Anne Balloch; Fiona M Russell; Robert L Burton; Jisheng Lin; Moon H Nahm; Edward K Mulholland; Mimi L K Tang
Journal:  J Allergy Clin Immunol       Date:  2012-02-02       Impact factor: 10.793

2.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 3.  Advances in basic and clinical immunology in 2010.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

4.  Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function.

Authors:  Paul V Licciardi; Anne Balloch; Fiona M Russell; Moon H Nahm; Kim Mulholland; Mimi L K Tang
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

5.  Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used.

Authors:  Anne Balloch; Paul V Licciardi; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

6.  Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.

Authors:  H Schaballie; G Wuyts; D Dillaerts; G Frans; L Moens; M Proesmans; F Vermeulen; K De Boeck; I Meyts; X Bossuyt
Journal:  Clin Exp Immunol       Date:  2016-05-20       Impact factor: 4.330

Review 7.  Educational paper: primary antibody deficiencies.

Authors:  Gertjan Driessen; Mirjam van der Burg
Journal:  Eur J Pediatr       Date:  2011-05-05       Impact factor: 3.183

Review 8.  Specific Antibody Deficiency: Controversies in Diagnosis and Management.

Authors:  Elena Perez; Francisco A Bonilla; Jordan S Orange; Mark Ballow
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561

9.  Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial.

Authors:  William S Pomat; Anita H J van den Biggelaar; Suparat Phuanukoonnon; Jacinta Francis; Peter Jacoby; Peter M Siba; Michael P Alpers; John C Reeder; Patrick G Holt; Peter C Richmond; Deborah Lehmann
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

Review 10.  [Humoral immunodeficiency : awareness for better support].

Authors:  Jalila El Bakkouri; Zahra Aadam; Fatima Ailal; Hanane Salih Alj; Ahmed Aziz Bousfiha
Journal:  Pan Afr Med J       Date:  2014-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.